Hyderabad, March 20 -- Bharat Biotech International Limited (BBIL), a pioneer in affordable indigenous vaccine development and manufacturing, on Thursday announced its foray into Cell & Gene Therapy (CGT).
In a release, the Hyderabad based vaccine maker also informed that it's Viral Vector Production at Genome Valley - expanding its expertise from vaccine innovation to leading-edge regenerative and personalised therapies that promise hope for millions.
This ushers in a new era of gene and cell therapies to tackle scientific challenges-such as targeted gene expression, immune system modulation, and long-term cell survival- The work will span from boosting immune responses against cancer to ensuring that therapeutic proteins are safely acce...